South Africa Non-alcoholic Steatohepatitis Biomarkers Market Size & Outlook
South Africa non-alcoholic steatohepatitis biomarkers market, 2018-2030 (US$M)
Related Markets
South Africa non-alcoholic steatohepatitis biomarkers market highlights
- The South Africa non-alcoholic steatohepatitis biomarkers market generated a revenue of USD 3.0 million in 2021 and is expected to reach USD 18.1 million by 2030.
- The South Africa market is expected to grow at a CAGR of 21.9% from 2022 to 2030.
- In terms of segment, serum biomarkers was the largest revenue generating type in 2021.
- Hepatic Fibrosis Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
Non-alcoholic steatohepatitis biomarkers market data book summary
| Market revenue in 2021 | USD 3.0 million |
| Market revenue in 2030 | USD 18.1 million |
| Growth rate | 21.9% (CAGR from 2021 to 2030) |
| Largest segment | Serum biomarkers |
| Fastest growing segment | Hepatic Fibrosis Biomarkers |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers |
| Key market players worldwide | Genfit SA, Siemens AG, Quest Diagnostics Inc, AstraZeneca PLC, Meridian Bioscience, Labcorp Holdings Inc, Pfizer Inc, Bristol-Myers Squibb Co |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.4% of the global non-alcoholic steatohepatitis biomarkers market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia non-alcoholic steatohepatitis biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 11.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-alcoholic Steatohepatitis Biomarkers Market Scope
Non-alcoholic Steatohepatitis Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa non-alcoholic steatohepatitis biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-alcoholic steatohepatitis biomarkers market will help companies and investors design strategic landscapes.
Serum biomarkers was the largest segment with a revenue share of 33.33% in 2021. Horizon Databook has segmented the South Africa non-alcoholic steatohepatitis biomarkers market based on serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.
Growing national and international collaborations in South Africa targeted toward improving public health have resulted in an increase in the adoption of biomarkers in the country. Moreover, companies such as SGS SA are collaborating with the clinical team for development and validation of innovative biomarker assays, which is boosting the market growth.
Various biomarkers are currently being developed for diagnosis, treatment, and monitoring of NASH, which is highly prevalent in adults aged 18 and above. The reported frequency of NAFLD in the general population in Africa is understated.
NAFLD is a hidden threat in Africa due to the long-term effects of growing obesity and type 2 diabetes prevalence in this continent. Health authorities in African nations must be aware of this covert threat and devise tactical solutions to deal with it by assessing its scope, revising the national health plan, and effectively allocating healthcare resources.
Reasons to subscribe to South Africa non-alcoholic steatohepatitis biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa non-alcoholic steatohepatitis biomarkers market databook
-
Our clientele includes a mix of non-alcoholic steatohepatitis biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa non-alcoholic steatohepatitis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into South Africa non-alcoholic steatohepatitis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa non-alcoholic steatohepatitis biomarkers market size, by type, 2018-2030 (US$M)
South Africa Non-alcoholic Steatohepatitis Biomarkers Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
